首页> 外文期刊>Europace: European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology >Combined dyssynchrony and scar imaging with cardiac magnetic resonance imaging predicts clinical response and long-term prognosis following cardiac resynchronization therapy.
【24h】

Combined dyssynchrony and scar imaging with cardiac magnetic resonance imaging predicts clinical response and long-term prognosis following cardiac resynchronization therapy.

机译:不同步和疤痕成像与心脏磁共振成像相结合可预测心脏再同步治疗后的临床反应和长期预后。

获取原文
获取原文并翻译 | 示例
           

摘要

AIMS: Cardiac resynchronization therapy (CRT) is advocated in advanced heart failure; however, patient selection remains challenging. We examined the utility of multi-sequential cardiac magnetic resonance imaging (CMR) in predicting outcome after CRT. METHODS AND RESULTS: We performed multi-sequential CMR on 40 subjects with cardiomyopathy and advanced heart failure, despite optimized medical therapy. All patients had been recommended for CRT according to accepted clinical guidelines. Patients were defined by CMR as likely responders if they had significant mechanical dyssynchrony (> or =65 ms delay between septal and posterolateral wall contraction on cine imaging), and no transmural scarring of the anteroseptal or posterolateral wall on delayed contrast-enhanced imaging. Clinical composite score was recorded at baseline and 6 months post-CRT. Long-term follow-up (transplant-free survival) was 497 +/- 55 days post-CRT. A clinical response was achieved in 19/26 (73%) of the CMR-predicted responders and 2/12 (17%) of the CMR-predicted non-responders (P < 0.01, chi(2)). The sensitivity of CMR for prediction of clinical response to CRT was 90%, with a specificity of 59%. Transplant-free survival post-CRT was achieved in 88% of the CMR-predicted responders and 58% of the CMR-predicted non-responders (P < 0.05, Kaplan-Meier survival analysis). CONCLUSION: Multi-sequential CMR identifies patients with severe cardiomyopathy who will respond to CRT with a favourable long-term prognosis.
机译:目的:心脏再同步治疗(CRT)用于晚期心力衰竭。然而,患者选择仍然具有挑战性。我们检查了多序列心脏磁共振成像(CMR)在预测CRT后的结果中的效用。方法和结果:尽管优化了药物治疗,我们还是对40例患有心肌病和晚期心力衰竭的受试者进行了多序列CMR。根据公认的临床指南,所有患者均被推荐接受CRT。如果CMR显着的机械不同步(在影像学检查中间隔和后外侧壁之间延迟> 65ms或= 65 ms延迟),并且在延迟造影剂增强后没有隔壁或前外侧壁的透壁瘢痕形成,则CMR将患者定义为可能的反应者。在基线和CRT后6个月记录临床综合评分。长期随访(无移植生存期)为CRT后497 +/- 55天。在CMR预测的无反应者中有19/26(73%)和CMR预测的无反应者中有2/12(17%)实现了临床反应(P <0.01,chi(2))。 CMR预测对CRT的临床反应的敏感性为90%,特异性为59%。 88%的CMR预测的应答者和58%的CMR预测的非应答者实现了CRT后的无移植生存(P <0.05,Kaplan-Meier生存分析)。结论:多序列CMR可以识别出严重的心肌病患者,这些患者对CRT有良好的长期预后。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号